NEW YORK (GenomeWeb News) – Bruker has named Charles Wagner to be its new executive VP and chief financial officer, beginning at the end of June, Bruker said this week. Current CFO William Knight will continue to serve on the company's management team and will work with Wagner to ensure a smooth transition. Wagner also has stepped down from his positions on Bruker's board of directors and its audit committee, where he has served since 2010.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

By analyzing tweets, Canadian researchers examine the public's view of gene patenting.

In Science this week: issues in reproducibility, circulating DNA predicts breast cancer relapse, and more.

Because of an autoimmune disorder, a man has been shedding live polioviruses for 28 years, according to an analysis appearing in PLOS Pathogens.

Being in a long-term collaboration can increase researchers' citation rates by 17 percent, a recent analysis says.